Ozempic & Wegovy: These FDA-approved medications have been rigorously tested for both weight loss and diabetes management
Public-private partnerships and ongoing innovation in telehealth technology can open new doors for patients, making care more efficient, effective, and accessible
It was designed to address inflammation, tissue damage, impaired healing, and cellular dysfunction simultaneously , making it uniquely suited for patients dealing with chronic inflammation, injury recovery, gut dysfunction, and accelerated aging processes
Their medically supervised weightloss program relies on FDAapproved GLP1 medications such as Ozempic, Wegovy, Mounjaro, and daily liraglutide (Saxenda or Victoza), ensuring safe continuity even as compounded alternatives face regulatory limitations
Clinical studies have shown that measurable weight loss often becomes noticeable within 4 to 8 weeks